Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ERIKA G GONZALEZ

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1427022516
CMS profile
337313
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$78,009.48

  • Reported across 526 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$866.32

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $809.32 37
Education $57.00 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $28,582.56 110
PY2019 $9,654.73 49
PY2020 $9,134.60 36
PY2021 $11,046.80 67
PY2022 $8,891.41 112
PY2023 $9,833.06 114
PY2024 $866.32 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $18.78 02/20/2024 Food and Beverage Undisputed 01/23/2026 1105792140 CMS
AstraZeneca Pharmaceuticals LP $16.91 03/19/2024 Food and Beverage Undisputed 01/23/2026 1104320322 CMS
AstraZeneca Pharmaceuticals LP $20.11 03/26/2024 Food and Beverage Undisputed 01/23/2026 1105702432 CMS
AstraZeneca Pharmaceuticals LP $18.58 04/09/2024 Food and Beverage Undisputed 01/23/2026 1104584182 CMS
AstraZeneca Pharmaceuticals LP $32.73 04/24/2024 Food and Beverage Undisputed 01/23/2026 1104471598 CMS
AstraZeneca Pharmaceuticals LP $20.24 07/24/2024 Food and Beverage Undisputed 01/23/2026 1105342480 CMS
AstraZeneca Pharmaceuticals LP $13.57 10/31/2024 Food and Beverage Undisputed 01/23/2026 1105804804 CMS
AstraZeneca Pharmaceuticals LP $18.63 12/10/2024 Food and Beverage Undisputed 01/23/2026 1104583684 CMS
Genentech USA, Inc. $20.24 01/02/2024 Food and Beverage Undisputed 01/23/2026 1133009040 CMS
Genentech USA, Inc. $25.20 02/26/2024 Food and Beverage Undisputed 01/23/2026 1133009044 CMS
Genentech USA, Inc. $16.52 08/13/2024 Food and Beverage Undisputed 01/23/2026 1133009048 CMS
GENZYME CORPORATION $35.47 03/06/2024 Food and Beverage Undisputed 01/23/2026 1139766952 CMS
GENZYME CORPORATION $22.06 03/28/2024 Food and Beverage Undisputed 01/23/2026 1139766958 CMS
GENZYME CORPORATION $18.35 04/01/2024 Food and Beverage Undisputed 01/23/2026 1139766962 CMS
GENZYME CORPORATION $38.24 07/24/2024 Food and Beverage Undisputed 01/23/2026 1139767006 CMS
GENZYME CORPORATION $27.81 10/23/2024 Food and Beverage Undisputed 01/23/2026 1139767048 CMS
GlaxoSmithKline, LLC. $20.44 05/14/2024 Food and Beverage Undisputed 01/23/2026 1116556245 CMS
GlaxoSmithKline, LLC. $22.71 08/27/2024 Food and Beverage Undisputed 01/23/2026 1116630292 CMS
GlaxoSmithKline, LLC. $57.00 09/09/2024 Education Undisputed 01/23/2026 1116216757 CMS
Grifols USA, LLC $24.42 10/14/2024 Food and Beverage Undisputed 01/23/2026 1124752617 CMS
Novartis Pharmaceuticals Corporation $17.10 02/13/2024 Food and Beverage Undisputed 01/23/2026 1086939237 CMS
Novartis Pharmaceuticals Corporation $30.87 04/05/2024 Food and Beverage Undisputed 01/23/2026 1086939239 CMS
Novartis Pharmaceuticals Corporation $21.94 04/29/2024 Food and Beverage Undisputed 01/23/2026 1086939241 CMS
Novartis Pharmaceuticals Corporation $21.82 08/06/2024 Food and Beverage Undisputed 01/23/2026 1086939245 CMS
Regeneron Healthcare Solutions, Inc. $27.29 01/08/2024 Food and Beverage Undisputed 01/23/2026 1114057876 CMS
Regeneron Healthcare Solutions, Inc. $27.54 09/03/2024 Food and Beverage Undisputed 01/23/2026 1114057878 CMS
Regeneron Healthcare Solutions, Inc. $13.44 10/01/2024 Food and Beverage Undisputed 01/23/2026 1114057880 CMS
SANOFI-AVENTIS U.S. LLC $7.44 01/31/2024 Food and Beverage Undisputed 01/23/2026 1139766946 CMS
SANOFI-AVENTIS U.S. LLC $11.86 03/07/2024 Food and Beverage Undisputed 01/23/2026 1139766950 CMS
SANOFI-AVENTIS U.S. LLC $18.48 04/11/2024 Food and Beverage Undisputed 01/23/2026 1139766974 CMS
SANOFI-AVENTIS U.S. LLC $15.30 05/08/2024 Food and Beverage Undisputed 01/23/2026 1139766982 CMS
SANOFI-AVENTIS U.S. LLC $17.53 05/22/2024 Food and Beverage Undisputed 01/23/2026 1139766980 CMS
SANOFI-AVENTIS U.S. LLC $16.42 06/13/2024 Food and Beverage Undisputed 01/23/2026 1139766990 CMS
SANOFI-AVENTIS U.S. LLC $30.21 07/08/2024 Food and Beverage Undisputed 01/23/2026 1139766992 CMS
SANOFI-AVENTIS U.S. LLC $20.43 07/25/2024 Food and Beverage Undisputed 01/23/2026 1139766996 CMS
SANOFI-AVENTIS U.S. LLC $33.23 08/14/2024 Food and Beverage Undisputed 01/23/2026 1139767004 CMS
SANOFI-AVENTIS U.S. LLC $19.30 09/26/2024 Food and Beverage Undisputed 01/23/2026 1139767034 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.11 05/08/2024 Food and Beverage Undisputed 01/23/2026 1137559122 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.